SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-055699
Filing Date
2021-04-27
Accepted
2021-04-27 17:18:22
Documents
5
Period of Report
2021-06-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm212466d4_def14a.htm DEF 14A 623901
2 GRAPHIC image_001.jpg GRAPHIC 17211
3 GRAPHIC image_002.jpg GRAPHIC 45560
4 GRAPHIC tm212466d4_def14aimg001.jpg GRAPHIC 129611
5 GRAPHIC tm212466d4_def14aimg002.jpg GRAPHIC 104983
  Complete submission text file 0001104659-21-055699.txt   1035084
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38129 | Film No.: 21860093
SIC: 2834 Pharmaceutical Preparations